Zhang K, Li R, Matniyaz Y, Yu R, Pan J, Liu W, et al
This glucagon-like peptide-1 (GLP-1) receptor agonist works by enhancing insulin secretion, suppressing appetite, and slowing gastric emptying
Overall, when administering GLP-1RA plus SGLT2i combination therapy, it is important to adopt an individualized approach to therapy taking into account individual preferences, costs and coverage, AE profile, consideration of kidney function and glucose-lowering efficacy, desire for weight loss, and comorbidities such as frailty [6, 22, 24]
I 2 = 0%), menstrual regularity, insulin sensitivity, and multiple anthropometric and hormonal parameters (Zhou et al., 2023)
Contact your pharmacist immediately, as these signs may indicate contamination or degradation that makes the medication unsafe